Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1994-08-09
1996-05-07
Dees, Jose G.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514359, 514438, 514461, 514617, 514620, 514619, 546348, 548250, 548254, 548400, 548566, 548567, 549 61, 549 74, 549 29, 549426, 549356, 549429, 549491, 549497, 560 10, 560 21, 560 25, 560 28, 560 56, 560 80, 562427, 562434, 562443, 562444, 562448, 562452, 562466, 564164, 564165, 564166, 564172, 564180, 558388, 558411, A61K 31435, A61K 3141, A61K 3138, A61K 3134
Patent
active
055146830
ABSTRACT:
The compounds of the formula I ##STR1## and their pharmaceutical acceptable salts, which are defined herein, are ligands for cholecystokinin and/or gastrin receptors.
REFERENCES:
patent: 3422104 (1969-01-01), Schroter et al.
patent: 3577366 (1971-05-01), Klandermann et al.
patent: 3950407 (1976-04-01), Hammar
patent: 4306063 (1981-12-01), Umen
patent: 5055468 (1991-10-01), Gray et al.
patent: 5332820 (1994-07-01), Duncia
Weber et al., "Design of Roof-Shaped Clathrate Hosts. Inclusion Properties and X-ray Crystal Structures of a Free Host and of Inclusion Compounds . . . " J. Org. Chem. 53:5831-5839 (Dec. 9, 1988).
Czugler et al., "Selective Clathrate Formation with the New Host Systems cis- and trans-9,10-Dihydro-9,10-ethanoanthracene-11,12-dicarboxylic Acid . . . " J. Chem. Soc. Chem. Comm. 23:1632-1634 (1984).
Singh et al., "PMR Spectral Studies of Diels-Alder Adducts: Anthracene-Coronic Acid, Anthracene-Fumaric Acid & .beta.-Naphthol-Fumaric Acid," Indian J. Chem. 23B:631-634 (Jul. 1984).
Russell et al., "Aliphatic Semidiones. XIX. Polycyclic Derivatives of Cyclobutanesemidione," J. Am. Chem. Soc. 94:1693-1698 (Mar. 8, 1972).
Tolbert et al., "Transition States in Catalyzed and Uncatalyzed Diels-Alder Reactions. Cooperativity as a Probe of Geometry," J. Am. Chem. Soc. 106:3806-3810 (1984).
Thebtaranonth, "The Use of Anthracene Adducts in the Synthesis of Natural Products," Proc. Asian Symp. Med. Plants Species 1:321-329 (1981).
Leclerco et al., "Etude Des Melanges D'Antipodes Optiques-XII," Tetrahedron 32:821-828 (1976).
Brienne et al., "No. 14.-Etude des melanges d'antipodes optiques. VI.-Derives du dihydro-9,10 ethano-9,10anthracene," Bull. Soc. Chim., Fr. 1:190-197 (1973).
Hagishita et al., "Optical Activity of C.sub.2 Symmetrical 9,10-Dihydro-9,10-Ethanoanthracenes," Tetrahedron 28:1435-1467 (1972).
Cristol et al., "Bridged Polycyclic Compounds. 83. Steric and Bromine Substituent Acceleration in Bromination Reactions". J. Org. Chem. 41:1919-1926 (1976).
Boissier et al., "Synthesis and Pharmacological Properties of New 9,10-Dihydro-9,10-ethanoanthracene Derivatives," J. Med. Chem. 10:86-91 (Jan. 1967).
Nanu et al., "Esters of 9,10-dihydroanthracene-endo-.alpha.,.beta.-succinic acid as models for the study of large-molecule plasticizers," Chem. Abs. 73:3680, abstract no. 3689Z (Jul. 6, 1970).
Bodkin Michael J.
Buck Ildiko M.
Davies Jonathan M. R.
Dunstone David J.
Harper Elaine A.
Conrad, III Joseph M.
Dees Jos,e G.
James Black Foundation Limited
LandOfFree
Bicyclo 2,2,2!octane derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Bicyclo 2,2,2!octane derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Bicyclo 2,2,2!octane derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1227448